Herceptin Hylecta
Generic: Trastuzumab and hyaluronidase-oysk
- Manufacturer
- Genentech
- NDC
- 50242-077
- RxCUI
- 2119714
- Route
- SUBCUTANEOUS
- ICD-10 indication
- C50.919
Affordability Check
How much will you actually pay for Herceptin Hylecta?
In 30 seconds, see every legitimate way to afford Herceptin Hylecta — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.
About Herceptin Hylecta
What is this medication?
Herceptin Hylecta is a prescription medication used to treat adults with specific types of HER2-positive breast cancer. This includes cases of early-stage breast cancer as part of a complete treatment plan after surgery, as well as metastatic breast cancer that has spread to other areas of the body. The medication specifically targets cancers that overexpress the human epidermal growth factor receptor 2 protein, which is responsible for signaling cancer cells to grow and divide.
The medication consists of a combination of trastuzumab and hyaluronidase-oysk. Trastuzumab is the active biologic agent that blocks the HER2 receptors, while hyaluronidase-oysk is an enzyme that helps the body absorb the medicine under the skin. Unlike original Herceptin which requires a lengthy intravenous infusion, Herceptin Hylecta is administered as a subcutaneous injection, which typically takes only a few minutes to complete during a clinic visit.
Copay & patient assistance
- Patient Copay Amount: Not Publicly Available
- Maximum Annual Benefit Limit: Not Publicly Available
- Core Eligibility Restrictions: Patients must provide personal information (name, address, insurance), prescribing doctor's information, and financial eligibility information including household size and annual net household income (though financial info is not required for all programs).
- RxBIN, PCN, and Group numbers: Not Publicly Available
External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.
Compare pricing elsewhere
RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.
Cost Plus Drug Company
Mark Cuban's transparent-pricing pharmacy — manufacturer cost + 15% markup + $5 dispensing fee. No insurance needed. Search alphabetically for Trastuzumab and hyaluronidase-oysk.
Browse Cost Plus medications →
GoodRx
Compare local pharmacy prices with GoodRx coupons. Use the price with your insurance or without — whichever is cheaper.
Lookup Herceptin Hylecta →
NeedyMeds
Independent nonprofit directory of patient assistance programs, copay cards, and charity co-pay foundations.
Search for Trastuzumab and hyaluronidase-oysk →
RxAssist
PAP directory maintained by Volunteers in Health Care at Brown University. Free, no ads.
Search PAPs →
We deep-link because transparency helps patients. None of these partners pay RxCopays.
Conditions we've indexed resources for
Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.
Prior authorization & coverage
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
Related drugs
EVEROLIMUS
Treats same condition · Everolimus
AVMAPKI FAKZYNJA CO-PACK
Treats same condition · avutometinib potassium and defactinib hydrochloride
Fludeoxyglucose F18
Treats same condition · Fludeoxyglucose F18
Portrazza
Treats same condition · necitumumab
Pilocarpine Hydrochloride
Treats same condition · Pilocarpine Hydrochloride
TEPADINA
Treats same condition · THIOTEPA
AVGEMSI
Treats same condition · Gemcitabine
CLENPIQ
Treats same condition · SODIUM PICOSULFATE, MAGNESIUM OXIDE, and ANHYDROUS CITRIC ACID
Niva Thyroid
Treats same condition · thyroid, porcine
Kisunla
Treats same condition · donanemab-azbt
How this page is sourced
- Drug identity verified against openFDA NDC Directory.
- Label text (when shown) originates from NLM DailyMed.
- Copay and assistance URLs verified periodically; if you hit a broken link, tell us.